Active — Not RecruitingNot Applicable

Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT

United States6 participantsStarted 2014-01-30

Plain-language summary

This pilot clinical trial studies positron emission tomography (PET)/computed tomography (CT) in finding beads after Yttrium-90 bead therapy in patients with primary liver cancer or cancer that has spread to the liver (metastatic) that can not be removed by surgery. Imaging procedures, such as PET/CT after Yttrium-90 bead therapy, may help see if the beads are present in the lung and compare the results with the pre-therapy imaging.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who undergo intra-arterial hepatic 99mTc MAA evaluation in anticipation of 90Y microsphere radioembolization Exclusion Criteria: * Patients who are unable to give consent * Prisoners

What they're measuring

Absolute difference in post-therapy Yttrium-90 microsphere and pre-therapy Technetium-99m macroaggregated albumin hepatopulmonary shunt fraction values

Timeframe: Baseline to up to 36 hours after radioembolization

Trial details

NCT IDNCT02119065

SponsorUniversity of Cincinnati

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2015-07-01

View on ClinicalTrials.gov More Advanced Adult Primary Liver Cancer trials